Cargando…
Nexrutine(®) preserves muscle mass similar to exercise in prostate cancer mouse model
Muscle loss is a debilitating side effect to prostate cancer (PCa) experienced by nearly 60% of men. The purpose of this study was to test the hypothesis that Nexrutine(®), a bark extract from the Phellodendrum amurense, can protect against prostate cancer induced muscle loss in a similar manner as...
Autores principales: | Patel, Darpan I., Wallace, Derek, Abuchowski, Kira, Rivas, Paul, Gallegos, Amber, Musi, Nicolas, Kumar, Addanki Pratap. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712237/ https://www.ncbi.nlm.nih.gov/pubmed/31456341 http://dx.doi.org/10.14814/phy2.14217 |
Ejemplares similares
-
Nexrutine and exercise similarly prevent high grade prostate tumors in transgenic mouse model
por: Patel, Darpan I., et al.
Publicado: (2019) -
Exercise preserves muscle mass and force in a prostate cancer mouse model
por: Patel, Darpan I., et al.
Publicado: (2019) -
Pilot Study on the Impact of a Home-Based Exercise Program on
Inflammatory Cytokines and Quality of Life in Men with Prostate Cancer Under
Active Surveillance
por: Moon, Crisann, et al.
Publicado: (2022) -
A randomized controlled trial of a home-based exercise program on prognostic biomarkers in men with prostate cancer: A study protocol
por: Patel, Darpan I., et al.
Publicado: (2020) -
Safety studies of Nexrutine, bark extract of Phellodendron amurense through repeated oral exposure to rats for 28 days
por: Alam, Shamshad, et al.
Publicado: (2021)